Cohance Lifesciences Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 19, 2025
COHANCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Cohance Lifesciences has notified stock exchanges that its 7th Annual General Meeting will be held on Friday, September 19, 2025 at 2:30 PM IST through video conferencing. Shareholders will consider four items: (1) adoption of audited standalone and consolidated financial statements for FY25; (2) re-appointment of Dr. V. Prasada Raju, who retires by rotation; (3) approval of remuneration payable to Dr. Prasada Raju as Managing Director, comprising a fixed pay of Rs 4.60 crore and variable pay of Rs 87.42 lakh per annum; and (4) appointment of M/s Makarand M. Joshi & Co. as Secretarial Auditors for a five-year term from FY26 to FY30. E-voting will run from September 15 (9:00 AM) to September 18, 2025 (5:00 PM), with a cut-off date of September 12, 2025. The AGM follows the recent merger of erstwhile Cohance Lifesciences with the company effective May 1, 2025.
This is a routine AGM notice with no major surprises. The MD remuneration being sought is the same as what Dr. Prasada drew from the merged entity, and the auditor appointment is standard. No material impact on the stock is expected from this disclosure alone.